The therapeutic potential of circular RNA in triple-negative breast cancer

Abstract

Triple-negative breast cancer (TNBC) is among the most aggressive subtypes of the disease that does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Circular RNAs (circRNAs) are a type of non-coding RNA with a circular shape formed by non-standard splicing or reverse splicing. Numerous circRNAs exhibit abnormal expression in various malignancies, showing their critical role in the emergence and growth of tumors. Recent studies have shown evidence supporting the idea that certain circRNAs regulate the proliferation and metastasis of TNBC. In addition, circRNAs alter metabolism and the immune microenvironment to promote or inhibit the development of TNBC. Notably, circRNAs may affect the efficacy of clinical drug therapy, serve as therapeutic targets, and be used as molecular biomarkers in the future. Herein, we will first summarize the biogenesis and function of circRNAs. Then, we will explain current research on circRNAs related to TNBC and their potential to serve as therapeutic targets or biomarkers for future drug development, providing a new direction and idea for TNBC therapy.

Keywords

Triple-negative breast cancer / circular RNA / non-coding RNA

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Perou CM,Eisen MB.Molecular portraits of human breast tumours.Nature2000;406:747-52

[3] Ensenyat-mendez M,Orozco JIJ.Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer.Front Oncol2021;11:681476 PMCID:PMC8242253

[4] Yin L,Bian X.Triple-negative breast cancer molecular subtyping and treatment progress.Breast Cancer Res2020;22:61 PMCID:PMC7285581

[5] Asleh K,Nielsen TO.Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.J Exp Clin Cancer Res2022;41:265 PMCID:PMC9434975

[6] Xie J,Deng X.Circular RNA: a promising new star of vaccine.J Transl Int Med2023;11:372-81 PMCID:PMC10732498

[7] Vo JN,Zhang Y.The landscape of circular RNA in cancer.Cell2019;176:869-81.e13 PMCID:PMC6601354

[8] Zeng Y,Gao G.The biogenesis, function and clinical significance of circular RNAs in breast cancer.Cancer Bio Med2021;19:14-29. PMCID:PMC8763001

[9] Hansen TB,Clausen BH.Natural RNA circles function as efficient microRNA sponges.Nature2013;495:384-8

[10] Zeng Y,Huang Z.Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205.Cell Death Discov2023;9:153 PMCID:PMC10169853

[11] Ye F,Zou Y.circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer.Mol Ther Nucleic Acids2019;18:88-98 PMCID:PMC6796723

[12] Hsu MT.Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells.Nature1979;280:339-40

[13] Cocquerelle C,Hétuin D.Mis-splicing yields circular RNA molecules.FASEB J1993;7:155-60

[14] Chen L,Sun H.The bioinformatics toolbox for circRNA discovery and analysis.Brief Bioinform2021;22:1706-28 PMCID:PMC7986655

[15] Memczak S,Elefsinioti A.Circular RNAs are a large class of animal RNAs with regulatory potency.Nature2013;495:333-8

[16] Haynes B,Nangia-makker P.Breast cancer complexity: implications of intratumoral heterogeneity in clinical management.Cancer Metastasis Rev2017;36:547-55 PMCID:PMC5693662

[17] Zhang C.RNA therapeutics: updates and future potential.Sci China Life Sci2023;66:12-30 PMCID:PMC9470505

[18] Rong Z,Shi S.Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment.Theranostics2021;11:2755-69 PMCID:PMC7806488

[19] Liu CX.Circular RNAs: characterization, cellular roles, and applications.Cell2022;185:2016-34

[20] Li X,Lei YN.Linking circular intronic RNA degradation and function in transcription by RNase H1.Sci China Life Sci2021;64:1795-809

[21] Conn VM,Nayak A.A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation.Nature Plants2017;3:17053

[22] Jeck WR,Wang K.Circular RNAs are abundant, conserved, and associated with ALU repeats.RNA2013;19:141-57 PMCID:PMC3543092

[23] Zhang X,Zhang Y,Chen L.Complementary sequence-mediated exon circularization.Cell2014;159:134-47

[24] Conn S,Toubia J.The RNA binding protein quaking regulates formation of circRNAs.Cell2015;160:1125-34

[25] Errichelli L,Laneve P.FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons.Nat Commun2017;8:14741 PMCID:PMC5379105

[26] Ashwal-fluss R,Pamudurti N.circRNA biogenesis competes with pre-mRNA splicing.Molecular Cell2014;56:55-66

[27] Guo Y,Huang Q.Circular RNAs and their roles in head and neck cancers.Mol Cancer2019;18:44 PMCID:PMC6427840

[28] Zhang Y,Chen T.Circular intronic long noncoding RNAs.Mol Cell2013;51:792-806

[29] Hoque P,Akins RE.Exploring the multifaceted biologically relevant roles of circRNAs: from regulation, translation to biomarkers.Cells2023;12:2813 PMCID:PMC10741722

[30] Xin R,Gao Y.isoCirc catalogs full-length circular RNA isoforms in human transcriptomes.Nat Commun2021;12:266 PMCID:PMC7803736

[31] Chiang TW,Chen YC,Wu WS.FL-circAS: an integrative resource and analysis for full-length sequences and alternative splicing of circular RNAs with nanopore sequencing.Nucleic Acids Res2024;52:D115-23 PMCID:PMC10767854

[32] Bartel DP.MicroRNAs: target recognition and regulatory functions.Cell2009;136:215-33 PMCID:PMC3794896

[33] Tay Y,Pandolfi PP.The multilayered complexity of ceRNA crosstalk and competition.Nature2014;505:344-52 PMCID:PMC4113481

[34] Verduci L,Yarden Y.The circ RNA-micro RNA code: emerging implications for cancer diagnosis and treatment.Mol Oncol2019;13:669-80 PMCID:PMC6441890

[35] Zou Y,Deng X.The role of circular RNA CDR1as/ciRS-7 in regulating tumor microenvironment: a pan-cancer analysis.Biomolecules2019;9:429 PMCID:PMC6770779

[36] Sang M,Liu S.Circular RNA ciRS-7 maintains metastatic phenotypes as a ceRNA of miR-1299 to target MMPs.Mol Cancer Res2018;16:1665-75

[37] Li Y,Zeng L.Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.Environ Res2023;239:117266

[38] Ding L.CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.Exp Mol Pathol2021;123:104704

[39] Ma J,Fan Z.CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis.Int J Biol Macromol2023;244:125295

[40] Huang S,Lei S,Zhang C.CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis.Mol Carcinog2023;62:450-63

[41] Dou D,Han M.CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.Cancer Cell Int2020;20:454 PMCID:PMC7491078

[42] He ZY,Yang SP.CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638 binding.Cell Signal2023;109:110787

[43] Wang F,Yu H.The circular RNA circFGFR4 facilitates resistance to anti-PD-1 of triple-negative breast cancer by targeting the miR-185-5p/CXCR4 axis.Cancer Manag Res2023;15:825-35 PMCID:PMC10439764

[44] Wang Z,Yang J.Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis.Cell Death Dis2022;13:776 PMCID:PMC9458743

[45] He Q,Wu Y,Jiang Y.CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-888 family/PDK1 axis.Life Sci2023;312:121128 PMCID:PMC10078949

[46] Shao G,Zhang P,Huang L.Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.Cell Biol Toxicol2023;39:2183-205

[47] Zan X,Wang G.Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway.Reprod Biol Endocrinol2022;20:138 PMCID:PMC9476576

[48] Gong G,Fu D,Zhang B.CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.Am J Cancer Res2022;12:2539-57 PMCID:PMC9251684

[49] Cui S,Xing L,Piao Y.Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis.Environ Toxicol2022;37:1483-94

[50] Wang X,Fang L.EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway.Cell Death Discov2022;8:92 PMCID:PMC8891274

[51] Wang M,Zhang H.Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.Inflamm Res2022;71:409-21

[52] Wang L,Zhou F,Li S.Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.Bioengineered2022;13:7197-208 PMCID:PMC8973968

[53] Maimaiti Y,Zhang Y,Song H.CircFAM64A enhances cellular processes in triple-negative breast cancer by targeting the miR-149-5p/CDT1 axis.Environ Toxicol2022;37:1081-92

[54] Li J,Zhang Z.CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.Mol Cancer2021;20:138 PMCID:PMC8543802

[55] Xing Z,Wang X.CircRNA circ-PDCD11 promotes triple-negative breast cancer progression via enhancing aerobic glycolysis.Cell Death Discov2021;7:218 PMCID:PMC8380247

[56] Huang Y,Lin Y.Circular RNA circ-ERBB2 elevates the warburg effect and facilitates triple-negative breast cancer growth by the microRNA 136-5p/pyruvate dehydrogenase kinase 4 axis.Mol Cell Biol2021;41:e00609-20 PMCID:PMC8462456

[57] Wang L,Jiang L.CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.Mol Cancer2021;20:43 PMCID:PMC7919093

[58] Fan Y,Jin W.CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.Mol Cancer2021;20:25 PMCID:PMC7851937

[59] Yang SJ,Zhong SL.Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.Cell Death Dis2021;12:420 PMCID:PMC8080849

[60] Wang X,Zhang Y,Duan X.Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.Cell Death Dis2021;12:412 PMCID:PMC8055688

[61] Du C,Zhang L,Wang Y.Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.J Gene Med2021;23:e3365 PMCID:PMC8459279

[62] Li H,Xia Z.Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.Aging2021;13:4522-51 PMCID:PMC7906206

[63] Xing L,Wang X.The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.Aging2020;12:10983-1003 PMCID:PMC7346060

[64] He D,Kuang W,Liu X.The novel circular RNA circ-PGAP3 promotes the proliferation and invasion of triple negative breast cancer by regulating the miR-330-3p/Myc axis.Onco Targets Ther2020;13:10149-59 PMCID:PMC7553664

[65] Kong Y,Wei W.CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.Epigenomics2019;11:1163-76

[66] Wu S,Zhu H.A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.Cancer Lett2024;581:216508

[67] Chen B,Huang X.circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression.Theranostics2018;8:4003-15 PMCID:PMC6071524

[68] Dudekula DB,Grammatikakis I,Abdelmohsen K.CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs.RNA Biology2016;13:34-42 PMCID:PMC4829301

[69] Pamudurti NR,Krishnamoorthy A.circMbl functions in cis and in trans to regulate gene expression and physiology in a tissue-specific fashion.Cell Rep2022;39:110740 PMCID:PMC9352392

[70] Luo P,Weng J.CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC progression.Cell Signal2023;108:110690

[71] Gao H,Li X.CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer.Cell Signal2023;109:110776

[72] Turco C,Iaiza A.MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.Commun Biol2022;5:598 PMCID:PMC9203778

[73] Song X,Liang Y.CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA.Cell Death Discov2022;8:261 PMCID:PMC9107465

[74] Abe N,Nishihara M.Rolling circle translation of circular RNA in living human cells.Sci Rep2015;5:16435 PMCID:PMC4639774

[75] Meyer K,Zhou J.5′ UTR m⁶A Promotes cap-independent translation.Cell2015;163:999-1010 PMCID:PMC4695625

[76] Song R,Ren X.A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer.Mol Cancer2023;22:104 PMCID:PMC10320902

[77] Li Y,Su P.circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway.Mol Ther2022;30:415-30 PMCID:PMC8753373

[78] Wang X,Luo Q.CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-211aa and regulating AKT phosphorylation.Cell Death Dis2022;13:794 PMCID:PMC9482637

[79] Li J,Yang X.Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.Mol Cancer2020;19:142 PMCID:PMC7488427

[80] Hao R,Si Y.A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis.Cancer Cell Int2023;23:54 PMCID:PMC10039515

[81] Ji C,Fang L.Hsa_circ_0000851 promotes PDK1/p-AKT-mediated cell proliferation and migration by regulating miR-1183 in triple-negative breast cancer.Cell Signal2023;101:110494

[82] Liu P,Ou X.The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition.Mol Cancer2022;21:198 PMCID:PMC9555172

[83] Ju C,Du D.EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression.Cell Death Dis2023;14:559 PMCID:PMC10457341

[84] Huang X,Liu Z.EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.Life Sci2023;324:121745

[85] Zheng W,Yu Y,Fang L.CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.Cell Mol Biol Lett2023;28:34 PMCID:PMC10131429

[86] Meng L,Sang Y.Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression.Breast Cancer Res2022;24:1 PMCID:PMC8725284

[87] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[88] Safi A,Sanaei M.The role of noncoding RNAs in metabolic reprogramming of cancer cells.Cell Mol Biol Lett2023;28:37 PMCID:PMC10169341

[89] Cai Z,Liao K,Chen D.Circular RNAs: emerging regulators of glucose metabolism in cancer.Cancer Lett2023;552:215978

[90] Ma W,Zhang S,Yu J.Circ_0039960 regulates growth and Warburg effect of breast cancer cells via modulating miR-1178/PRMT7 axis.Mol Cell Probes2022;64:101829

[91] Dou D,Han M.Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.Mol Oncol2021;15:697-709 PMCID:PMC7858101

[92] Cao L,Dong Y.Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2.Cell Death Dis2020;11:145 PMCID:PMC7039970

[93] Tian J,Yu C,Wang L.The role of non-coding RNAs in breast cancer drug resistance.Front Oncol2021;11:702082 PMCID:PMC8473733

[94] Tang AH,Guye ML.Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer.Cancer Drug Resist2022;5:691-702 PMCID:PMC9511813

[95] Xia M,Chen Z,Zhong J.Noncoding RNAs in triple negative breast cancer: mechanisms for chemoresistance.Cancer Lett2021;523:100-10

[96] Misir S,Petrović N,Hepokur C.circRNAs in drug resistance of breast cancer.Oncol Res2022;30:157-72 PMCID:PMC10208077

[97] Wang X,Li C.CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.J Hematol Oncol2022;15:122 PMCID:PMC9425971

[98] Wang X,Jin M.Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells.Aging2020;12:19095-106 PMCID:PMC7732319

[99] Wang J,Wang Y.circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma.Cell Death Dis2020;11:32 PMCID:PMC6965119

[100] Xu Y,Gao C.Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.Cell Signal2021;86:110095

[101] Gao C,J Qi L,Zhang L.CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.Cell Biol Toxicol2022;38:825-45

[102] Fu X,Tu S.Hsa_circ_0046523 mediates an immunosuppressive tumor microenvironment by regulating MiR-148a-3p/PD-L1 axis in pancreatic cancer.Front Oncol2022;12:877376 PMCID:PMC9192335

[103] Yang Z,Wang Y,Ji Y.CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression.Cell Biol Int2021;45:1423-35

[104] Luo Y,Xiang S,Zu X.Non-coding RNAs in breast cancer: implications for programmed cell death.Cancer Lett2022;550:215929

[105] Zheng Y,Zhang Y.Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4.Cancer Cell Int2022;22:264 PMCID:PMC9396792

[106] Lu C,Hu W.Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression.Pharmacol Res2022;177:106098

[107] Huang X,Zhang J,Tang H.Circular RNAs in breast cancer diagnosis, treatment and prognosis.Oncol Res2024;32:241-9 PMCID:PMC10765117

[108] Wang B,Deng Y.CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.J Transl Med2023;21:186 PMCID:PMC9999642

[109] Liu Y,He Y.Hypoxia-induced FUS-circTBC1D14 stress granules promote autophagy in TNBC.Adv Sci2023;10:2204988 PMCID:PMC10074116

[110] Darbeheshti F,Azizi-tabesh G.Evaluation of circ_0000977-mediated regulatory network in breast cancer: a potential discriminative biomarker for triple-negative tumors.Biochem Genet2023;61:1487-508

[111] Darbeheshti F,Mansoori Y.Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.Cancer Cell Int2021;21:312 PMCID:PMC8201848

[112] Zheng X,Xing L.The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.Mol Cancer2020;19:73 PMCID:PMC7137343

[113] Yu J,Xu J,Gao B.circUSP42 is downregulated in triple-negative breast cancer and associated with poor prognosis.Technol Cancer Res Treat2020;19:153303382095082 PMCID:PMC7502800

[114] Liu P,Li X.circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R axis.Front Genet2020;11:193 PMCID:PMC7066119

[115] Li Y,Zheng T,Jiang D.Circular RNA hsa_circ_0131242 promotes triple-negative breast cancer progression by sponging hsa-miR-2682.Onco Targets Ther2020;13:4791-8 PMCID:PMC7261810

[116] Zou Y,Xiao W.circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.Carcinogenesis2019;40:1469-79

[117] Xu J,Wang X.circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.Cell Death Dis2019;10:175 PMCID:PMC6382814

[118] Zhang J,Xing XJ,Xia ZH.CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.Eur Rev Med Pharmacol Sci2019;23:5315-22

[119] Xiao W,Zou Y.CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.Aging2019;11:12043-56 PMCID:PMC6949091

[120] Wang ST,Li XM.Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway.Neoplasma2019;66:232-9

[121] Tang H,Wang J.circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.Mol Cancer2019;18:23 PMCID:PMC6369546

[122] Zeng K,Yang BB.The pro-metastasis effect of circANKS1B in breast cancer.Mol Cancer2018;17:160 PMCID:PMC6240936

[123] He R,Xie X.circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.J Exp Clin Cancer Res2017;36:145 PMCID:PMC5644184

[124] Magalhães L,Cruz RL.Triple-negative breast cancer circRNAome reveals Hsa_circ_0072309 as a potential risk biomarker.Cancers2022;14:3280 PMCID:PMC9265318